1. Home
  2. CYCC vs MAXN Comparison

CYCC vs MAXN Comparison

Compare CYCC & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • MAXN
  • Stock Information
  • Founded
  • CYCC 1992
  • MAXN 2019
  • Country
  • CYCC Malaysia
  • MAXN Singapore
  • Employees
  • CYCC N/A
  • MAXN N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • MAXN Semiconductors
  • Sector
  • CYCC Health Care
  • MAXN Technology
  • Exchange
  • CYCC Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • CYCC 61.2M
  • MAXN 56.0M
  • IPO Year
  • CYCC N/A
  • MAXN N/A
  • Fundamental
  • Price
  • CYCC $0.32
  • MAXN $3.07
  • Analyst Decision
  • CYCC
  • MAXN Sell
  • Analyst Count
  • CYCC 0
  • MAXN 1
  • Target Price
  • CYCC N/A
  • MAXN $4.00
  • AVG Volume (30 Days)
  • CYCC 3.9M
  • MAXN 165.8K
  • Earning Date
  • CYCC 08-13-2025
  • MAXN 07-07-2025
  • Dividend Yield
  • CYCC N/A
  • MAXN N/A
  • EPS Growth
  • CYCC N/A
  • MAXN N/A
  • EPS
  • CYCC N/A
  • MAXN N/A
  • Revenue
  • CYCC $14,000.00
  • MAXN $509,048,000.00
  • Revenue This Year
  • CYCC $137.21
  • MAXN $100.37
  • Revenue Next Year
  • CYCC N/A
  • MAXN $24.61
  • P/E Ratio
  • CYCC N/A
  • MAXN N/A
  • Revenue Growth
  • CYCC N/A
  • MAXN N/A
  • 52 Week Low
  • CYCC $0.25
  • MAXN $2.49
  • 52 Week High
  • CYCC $39.84
  • MAXN $85.25
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 25.85
  • MAXN 49.86
  • Support Level
  • CYCC $0.31
  • MAXN $2.60
  • Resistance Level
  • CYCC $0.41
  • MAXN $3.04
  • Average True Range (ATR)
  • CYCC 0.07
  • MAXN 0.26
  • MACD
  • CYCC 0.10
  • MAXN 0.00
  • Stochastic Oscillator
  • CYCC 38.57
  • MAXN 54.02

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: